Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Primary Item (H2)Sub Item 1 (H3)Sub Item 2 (H4)
Sub Item 3 (H5)
Sub Item 4 (H6)

Published: August 24, 2021

Version 3.0

Authors:Ontario COVID-19 Drugs and Biologics Clinical Practice Guidelines Working Group on behalf of the Ontario COVID-19 Science Advisory Table

View PDF

https://doi.org/10.47326/ocsat.cpg.2021.3.0

OUTDATED

This version is outdated. Please see https://doi.org/10.47326/ocsat.cpg.2021.4.0 for the latest version of the Clinical Practice Guideline Summary.

Document Information & Citation

Citation: Ontario COVID-19 Drugs and Biologics Clinical Practice Guidelines Working Group. Clinical practice guideline summary: recommended drugs and biologics in adult patients with COVID-19. Ontario COVID-19 Science Advisory Table. 2021;Version 3.0. https://doi.org/10.47326/ocsat.cpg.2021.3.0

Author Affiliations: The affiliations of the members of the Ontario COVID-19 Science Advisory Table and the Drugs & Biologics Clinical Practice Guidelines Working Group can be found at https://covid19-sciencetable.ca/about.

Declarations of Interest: The declarations of interest of the members of the Ontario COVID-19 Science Advisory Table and the Drugs & Biologics Clinical Practice Guidelines Working Group can be found at https://covid19-sciencetable.ca/about.

Copyright: 2021 Ontario COVID-19 Science Advisory Table. This is an open access document distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.